This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pulmonary Hypertension
and you are
between 4 and 12
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The objective of this study was to assess the efficacy and appropriate dose of iloprost for inhalation in the treatment of postoperative pulmonary hypertension in children with congenital heart defects.

Provided treatments

  • Drug: iloprost nebuliser solution
  • Drug: iloprost nebuliser solution
  • Drug: distilled water

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01320878. The sponsor of the trial is Shanghai Jiao Tong University School of Medicine and it is looking for 64 volunteers for the current phase.
Official trial title:
A Randomized Controlled Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease